Image For Activity Cover
LQCL2215 - CMLE - PHARMACOGENOMIC TESTING FOR HIV-POSITIVE INDIVIDUALS
Course Description

LabQ 2022 Clinical Laboratory: Molecular Diagnostics Exercise   

Faculty/Authors

KRISTEN COFFEY, MS, MBCM (ASCP) 
UNIVERISTY OF WEST FLORIDA
Pensacola, Florida 

CMLE Credit: 2.0
Estimated Completion Time: 2 hour
Format: Online Educational Activity and Post Exam

 

Instructions

To claim CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Course to view an overview of the modules in this course.
  3. Click Access to begin the course.
  4. Review the Educational Activity.
  5. Complete and submit the Post Exam.
  6. Submit the course Evaluation to register your credit.

Faculty Disclosures​
The faculty have no relevant financial relationships with commercial interests to disclose.

Technical Considerations

Release Date: 05/27/2022 
Review Date:
Expiration Date: 12/31/2024 

Course Objectives
Following completion of this activity, you will be able to:
  • explain 2 factors that can contribute to virologic failure in treatment-experienced HIV-positive patients;  

  • differentiate virologic suppression from virologic failure using viral load thresholds; 

  • describe different classes of antiretroviral medications used in HIV-positive patients to achieve virologic suppression; 

  • predict how the mutations M184V, K103N/S, Y181 C/I/V, L76V, and E35D, will affect treatment outcomes in drugs targeted at reverse transcriptase and protease; and  

  • identify the polymorphism that predicts an adverse drug reaction with abacavir. 

Summary
Availability: On-Demand
Credit Offered:
2 CMLE Credits
Powered By